Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Victoza

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Victoza (liraglutide) is a modern antidiabetic drug of GLP1 (glucagone like peptide) analogue group; since 2009 registered in… Expand
Is this relevant?
2015
2015
AIMS The ROOTS study was an observational study to evaluate the effectiveness and safety of liraglutide (Victoza(®)), a GLP-1… Expand
Is this relevant?
Highly Cited
2014
Highly Cited
2014
AIM Two treatment strategies were compared in patients with type 2 diabetes (T2DM) on basal insulin requiring intensification… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
BACKGROUND Liraglutide is an analog of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist. Liraglutide is… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2010
2010
According to the Centers for Disease Control and Prevention (CDC) prevalence data for 2007, diabetes is a chronic and progressive… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2010
2010
  • 2010
  • Corpus ID: 8576272
WARNING: RISK OF THYROID C-CELL TUMORS See full prescribing information for complete boxed warning. • Liraglutide causes thyroid… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2010
2010
  • The Medical letter on drugs and therapeutics
  • 2010
  • Corpus ID: 25800817
Liraglutide (Victoza-Novo Nordisk), a glucagon-like peptide-1 (GLP-1) receptor agonist given by subcutaneous injection, has been… Expand
Is this relevant?
2010
2010
Liraglutide (Victoza) is a peptide produced by DNA recombinant technology, which presents 97% homology with human glucagon-like… Expand
Is this relevant?
2010
2010
New molecular entity: Liraglutide (Victoza) was approved January 25, 2010 to improve blood sugar control in adults with type 2… Expand
Is this relevant?